Brazil's Cyber Shock: Pure Global on ANVISA's Hidden Hurdles for Connected Devices.

In this episode, we dissect the breaking news from Brazil where ANVISA has just released an urgent and aggressive new cybersecurity resolution, RDC 999/2026. This sudden move imposes tight deadlines on both new and existing connected medical devices, forcing manufacturers to quickly adapt or risk losing market access in Latin America's largest market.

We explore the immediate impact on international MedTech companies, many of whom are now scrambling to meet the complex new requirements. This resolution is more than a simple compliance update; it's a signal of a major strategic shift in how Brazil, and potentially the rest of LATAM, will regulate the future of digital health technology.

**What You'll Learn:**
* What are the immediate, critical deadlines in ANVISA's new cybersecurity resolution?
* Why is simply translating your existing EU or FDA technical file no longer sufficient for Brazil?
* How does Brazil's data privacy law (LGPD) create unique challenges for device manufacturers?
* What is the single biggest risk facing legacy medical devices already on the Brazilian market?
* Could this regulatory shockwave in Brazil trigger a domino effect across Colombia and Mexico?
* What are the three essential steps your company must take now to avoid market access denial?
* How can you turn this regulatory hurdle into a competitive advantage in the LATAM region?

Struggling to keep up with the fast-changing regulatory landscape in Latin America? Pure Global offers end-to-end regulatory consulting solutions for MedTech and IVD companies. We combine local expertise with advanced AI and data tools to streamline your global market access, ensuring you're always ahead of the curve. Don't let regulatory surprises derail your strategy. Contact us at info@pureglobal.com or visit https://pureglobal.com/ to learn how we can secure and accelerate your entry into over 30 global markets.